TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Bronstein, Gewirtz & Grossman Llc
Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

A class action lawsuit has been filed against Telix Pharmaceuticals Limited (NASDAQ: TLX) alleging that company executives made false and misleading statements regarding the progress of prostate cancer therapeutic candidates and the quality of its supply chain during the period from February 21, 2025 to August 28, 2025. Investors who purchased Telix securities during this period are encouraged to join the case, with a lead plaintiff deadline of January 9, 2026.

Insights
TLX   negative

The company is the subject of a securities fraud class action lawsuit alleging material misstatements regarding therapeutic candidate progress and supply chain quality, indicating serious allegations of investor deception and potential financial harm.